| http://www.w3.org/ns/prov#value | - Specifically, the Act states that beginning April 1, 2012, and each year thereafter, each manufacturer and ADR of an applicable drug that makes distributions by mail, common carrier, or other means is required to report to the Secretary of the Department of Health and Human Services (Secretary) the identity and quantity of drug samples requested and distributed during the preceding calendar year.
|
